OnKure Therapeutics, Inc. (OKUR)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 1 signal for OnKure Therapeutics, Inc.. Most notable: 2026-08-13: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement, director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | Saccomano Nicholas A | director | S | 86 | 4.4 | $378 |
| 2026-06-22 | Leverone Jason A. | officer | S | 303 | 4.4 | $1,333 |
| 2026-06-22 | Saccomano Nicholas A | director | S | 86 | 4.4 | $378 |
| 2026-06-22 | Leverone Jason A. | officer | S | 303 | 4.4 | $1,332 |
| 2026-03-23 | Saccomano Nicholas A | director | S | 86 | 4.16 | $358 |
| 2026-03-23 | Leverone Jason A. | officer | S | 301 | 4.16 | $1,252 |
| 2026-03-23 | Saccomano Nicholas A | director | S | 86 | 4.16 | $357 |
| 2026-03-23 | Leverone Jason A. | officer | S | 301 | 4.16 | $1,251 |
| 2025-12-31 | Mathers Edward T | director | A | 3,911 | 0 | $0 |
| 2025-12-31 | Manke Isaac | director | A | 5,258 | 0 | $0 |
| 2025-12-31 | Mathers Edward T | director | A | 3,911 | 0 | $0 |
| 2025-12-31 | Manke Isaac | director | A | 5,258 | 0 | $0 |
| 2025-12-22 | Saccomano Nicholas A | director | S | 87 | 2.97 | $258 |
| 2025-12-22 | Leverone Jason A. | officer | S | 302 | 2.97 | $897 |
| 2025-12-22 | Saccomano Nicholas A | director | S | 87 | 2.97 | $258 |
| 2025-12-22 | Leverone Jason A. | officer | S | 302 | 2.97 | $896 |
| 2025-09-30 | Mathers Edward T | director | A | 4,125 | 0 | $0 |
| 2025-09-30 | Manke Isaac | director | A | 5,545 | 0 | $0 |
| 2025-09-30 | Mathers Edward T | director | A | 4,125 | 0 | $0 |
| 2025-09-30 | Manke Isaac | director | A | 5,545 | 0 | $0 |
| 2025-09-22 | Saccomano Nicholas A | director | S | 88 | 2.62 | $231 |
| 2025-09-22 | Leverone Jason A. | officer | S | 303 | 2.62 | $794 |
| 2025-09-22 | Saccomano Nicholas A | director | S | 88 | 2.62 | $231 |
| 2025-09-22 | Leverone Jason A. | officer | S | 303 | 2.62 | $795 |
| 2025-06-30 | Mathers Edward T | director | A | 4,694 | 0 | $0 |
| 2025-06-30 | Manke Isaac | director | A | 6,311 | 0 | $0 |
| 2025-06-30 | Mathers Edward T | director | A | 4,694 | 0 | $0 |
| 2025-06-30 | Manke Isaac | director | A | 6,311 | 0 | $0 |
| 2025-06-23 | Saccomano Nicholas A | director | S | 88 | 2.38 | $209 |
| 2025-06-23 | Leverone Jason A. | officer | S | 303 | 2.38 | $721 |
| 2025-06-23 | Saccomano Nicholas A | director | S | 88 | 2.38 | $210 |
| 2025-06-23 | Leverone Jason A. | officer | S | 303 | 2.38 | $722 |
| 2025-05-15 | Cormorant Private Healthcare Fund III LP | other | S | 1,813,439 | 1.85 | $3,354,862 |
| 2025-05-15 | ACORN CAPITAL ADVISORS GP, LLC | ten percent owner | P | 1,129,730 | 1.85 | $2,090,001 |
| 2025-05-15 | ACORN CAPITAL ADVISORS GP, LLC | ten percent owner | P | 270,270 | 1.85 | $500,000 |
| 2025-05-15 | Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP; Cormorant Private Healthcare Fund V LP; Chen Bihua | other | S | 1,813,439 | 1.85 | $3,363,023 |
| 2025-05-15 | ACORN BIOVENTURES, L.P.; ACORN CAPITAL ADVISORS GP, LLC; Hove Anders D | ten percent owner | P | 270,270 | 1.85 | $500,000 |
| 2025-05-15 | ACORN BIOVENTURES, L.P.; ACORN CAPITAL ADVISORS GP, LLC; Hove Anders D | ten percent owner | P | 1,129,730 | 1.85 | $2,090,001 |
| 2025-05-12 | Cormorant Global Healthcare Master Fund, LP | ten percent owner | S | 24,300 | 1.99 | $48,357 |
| 2025-05-12 | Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP; Cormorant Private Healthcare Fund V LP; Chen Bihua | ten percent owner | S | 24,300 | 1.99 | $48,236 |
| 2025-04-07 | Saccomano Nicholas A | director | S | 516 | 2.67 | $1,378 |
| 2025-04-07 | Leverone Jason A. | officer | S | 1,844 | 2.67 | $4,923 |
| 2025-04-07 | Saccomano Nicholas A | director | S | 516 | 2.67 | $1,378 |
| 2025-04-07 | Leverone Jason A. | officer | S | 1,844 | 2.67 | $4,925 |
| 2025-04-04 | Saccomano Nicholas A | director | S | 358 | 3.33 | $1,192 |
| 2025-04-04 | Leverone Jason A. | officer | S | 1,278 | 3.33 | $4,256 |
| 2025-04-04 | Saccomano Nicholas A | director | S | 358 | 3.33 | $1,191 |
| 2025-04-04 | Leverone Jason A. | officer | S | 1,278 | 3.33 | $4,253 |
| 2025-03-31 | Mathers Edward T | director | A | 2,580 | 0 | $0 |
| 2025-03-31 | Manke Isaac | director | A | 3,469 | 0 | $0 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-13 4/A
- 2026-08-13 8-K
- 2026-08-11 4
- 2026-08-11 4
- 2026-08-11 4
- 2026-08-11 4
- 2026-08-11 4
- 2026-08-11 4
- 2026-08-11 4
- 2026-08-11 4
- 2026-08-11 4
- 2026-08-11 4
- 2026-08-11 4
- 2026-08-10 SCHEDULE 13G/A
- 2026-08-04 424B5
- 2026-08-04 8-K
- 2026-08-04 10-Q